Private Ab TomEnterprise is 10% Owner at DiaMedica Therapeutics Inc. (DMAC). They have made 1 open-market trade across 1 company since 2024, most recently 2024-06-28.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.0M since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DMAC | 5,526,435 | $42.1M |
Shares reported on the most recent Form 4, priced at the 2024-07-01 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DMAC | BUY | 2024-06-28 | 2024-07-01 | $2.50 | $3.0M | +12.7% | +6.5% | +36.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.